Annual CFF
-$337.50M$170.10M-101.62%
Summary
- Current Value
- As of today, GDRX annual cash from financing is -$337.50M, down -101.62% on
- Historical Performance
- GDRX annual cash from financing is down -1005.53% over the past 3 years, and down -516.08% over the past 5 years
- All-Time High Comparison
- GDRX annual cash from financing is currently -137.26% below its historical high of $905.82M set on
- 3-Year Low Comparison
- GDRX annual cash from financing is at its 3-year low
- Sector Comparison
- GDRX annual cash from financing is higher than 6.78% of companies in Healthcare sector
Cash From Financing Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | -$337.50M | -101.6% | -1005.5% | -516.1% | – | |
| Quarterly Cash From Financing | -$65.81M | +61.8% | -203.1% | -106.6% | – | |
| TTM Cash From Financing | -$225.17M | +51.0% | -77.4% | -122.1% | – | |
| Price | $2.85 | -35.4% | -41.1% | -93.2% | – | |
| Annual Cash From Operations | $183.89M | +33.0% | +2.9% | +120.8% | – | |
| Annual Cash From Investing | -$70.35M | -26.1% | +60.6% | -89.8% | – | |
| Annual Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | – | |
| Annual Total Debt | $543.39M | -23.6% | -22.6% | -23.6% | +1079.3% | |
| Shares Outstanding | 339.43M | -11.3% | -14.5% | -13.3% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$120.23M | N/A | -180.7% |
| 5Y | $905.82M | N/A | -137.3% |
| All | $905.82M | -137.3% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$337.50M | at low | |
| 5Y | -$337.50M | at low | |
| All | -$337.50M | at low |
Cash From Financing History
| Year | Value | Change |
|---|---|---|
| -$337.50M | -101.6% | |
| -$167.40M | -39.2% | |
| -$120.23M | -293.8% | |
| -$30.53M | -103.4% |
| Year | Value | Change |
|---|---|---|
| $905.82M | +1,753.5% | |
| -$54.78M | -121.5% | |
| -$24.73M | - |
FAQ
What is the current annual cash from financing of GDRX?
As of today, GDRX annual cash from financing is -$337.50M
What is 1-year change in GDRX annual cash from financing?
GDRX annual cash from financing is down -101.62% year-over-year
What is 3-year change in GDRX annual cash from financing?
GDRX annual cash from financing is down -1005.53% over the past 3 years
How far is GDRX annual cash from financing from its all-time high?
GDRX annual cash from financing is currently -137.26% below its historical high of $905.82M set on December 31, 2020
How does GDRX annual cash from financing rank versus sector peers?
GDRX annual cash from financing is higher than 6.78% of companies in Healthcare sector
When is GDRX next annual earnings release?
The next annual earnings release for GDRX is on
Quarterly CFF
-$65.81M$14.89M-29.23%
Summary
- Current Value
- As of today, GDRX quarterly cash from financing is -$65.81M, down -29.23% on
- Historical Performance
- GDRX quarterly cash from financing is up +61.77% year-over-year, and down -203.13% over the past 3 years
- All-Time High Comparison
- GDRX quarterly cash from financing is currently -106.63% below its historical high of $992.12M set on
- 3-Year Low Comparison
- GDRX quarterly cash from financing is +61.77% above its 3-year low of -$172.13M reached on
- Sector Comparison
- GDRX quarterly cash from financing is higher than 7.79% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | -$65.81M | -29.2% | +61.8% | -203.1% | -106.6% | |
| Annual Cash From Financing | -$337.50M | – | -101.6% | -1005.5% | -516.1% | |
| TTM Cash From Financing | -$225.17M | +32.1% | +51.0% | -77.4% | -122.1% | |
| Price | $2.85 | -35.1% | -35.4% | -41.1% | -93.2% | |
| Quarterly Cash From Operations | $76.02M | +53.3% | -12.5% | +125.4% | +132.7% | |
| Quarterly Cash From Investing | -$18.00M | +1.7% | -13.5% | -30.7% | +75.5% | |
| Quarterly Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $545.14M | -0.4% | +0.1% | -21.9% | -25.7% | |
| Shares Outstanding | 339.43M | – | -11.3% | -14.5% | -13.3% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$3.53M | N/A | -1764.4% |
| 3Y | -$864.00K | -7517.3% | |
| 5Y | -$864.00K | -7517.3% | |
| All | $992.12M | -106.6% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$104.90M | +37.3% | |
| 3Y | -$172.13M | +61.8% | |
| 5Y | -$172.13M | +61.8% | |
| All | -$172.13M | +61.8% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of GDRX?
As of today, GDRX quarterly cash from financing is -$65.81M
What is GDRX quarterly cash from financing most recent change?
GDRX quarterly cash from financing was down -29.23% on September 30, 2025
What is 1-year change in GDRX quarterly cash from financing?
GDRX quarterly cash from financing is up +61.77% year-over-year
How far is GDRX quarterly cash from financing from its all-time high?
GDRX quarterly cash from financing is currently -106.63% below its historical high of $992.12M set on September 30, 2020
How does GDRX quarterly cash from financing rank versus sector peers?
GDRX quarterly cash from financing is higher than 7.79% of companies in Healthcare sector
When is GDRX next earnings release?
The next earnings release for GDRX is on
TTM CFF
-$225.17M$106.32M+32.07%
Summary
- Current Value
- As of today, GDRX TTM cash from financing is -$225.17M, up +32.07% on
- Historical Performance
- GDRX TTM cash from financing is up +51.00% year-over-year, and down -77.43% over the past 3 years
- All-Time High Comparison
- GDRX TTM cash from financing is currently -122.14% below its historical high of $1.02B set on
- 3-Year Low Comparison
- GDRX TTM cash from financing is +51.00% above its 3-year low of -$459.57M reached on
- Sector Comparison
- GDRX TTM cash from financing is higher than 9.42% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | -$225.17M | +32.1% | +51.0% | -77.4% | -122.1% | |
| Annual Cash From Financing | -$337.50M | – | -101.6% | -1005.5% | -516.1% | |
| Quarterly Cash From Financing | -$65.81M | -29.2% | +61.8% | -203.1% | -106.6% | |
| Price | $2.85 | -35.1% | -35.4% | -41.1% | -93.2% | |
| TTM Cash From Operations | $179.76M | -5.7% | +16.0% | +9.1% | +54.3% | |
| TTM Cash From Investing | -$104.83M | -2.1% | -57.5% | +52.6% | -28.1% | |
| TTM Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $545.14M | -0.4% | +0.1% | -21.9% | -25.7% | |
| Shares Outstanding | 339.43M | – | -11.3% | -14.5% | -13.3% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$225.17M | at high | |
| 3Y | -$42.92M | -424.7% | |
| 5Y | $905.82M | N/A | -124.9% |
| All | $1.02B | -122.1% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$337.50M | N/A | +33.3% |
| 3Y | -$459.57M | +51.0% | |
| 5Y | -$459.57M | +51.0% | |
| All | -$459.57M | +51.0% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of GDRX?
As of today, GDRX TTM cash from financing is -$225.17M
What is GDRX TTM cash from financing most recent change?
GDRX TTM cash from financing was up +32.07% on September 30, 2025
What is 1-year change in GDRX TTM cash from financing?
GDRX TTM cash from financing is up +51.00% year-over-year
How far is GDRX TTM cash from financing from its all-time high?
GDRX TTM cash from financing is currently -122.14% below its historical high of $1.02B set on September 30, 2020
How does GDRX TTM cash from financing rank versus sector peers?
GDRX TTM cash from financing is higher than 9.42% of companies in Healthcare sector
When is GDRX next earnings release?
The next earnings release for GDRX is on
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
Data Sources & References
- GDRX Official Website www.goodrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1809519/000180951925000143/0001809519-25-000143-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1809519/000180951925000040/0001809519-25-000040-index.htm
- GDRX Profile on Yahoo Finance finance.yahoo.com/quote/GDRX
- GDRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gdrx